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ABSTRACT
Insulin resistance is a homeorhetic adaptation to par-
turition in dairy cows transitioning from late pregnancy 
to early lactation. An increase in prepartum adiposity 
can predispose periparturient cows to greater lipoly-
sis and insulin resistance, thus increasing the risk for 
metabolic disease. Mechanisms mediating the devel-
opment of insulin resistance in overweight peripartal 
dairy cows may depend on ceramide metabolism. The 
sphingolipid ceramide accumulates in plasma and tis-
sues of overweight monogastric animals, and facilitates 
saturated fatty acid-induced insulin resistance. Con-
sidering this evidence, we hypothesized that plasma 
ceramides would be elevated in periparturient dairy 
cattle and that these sphingolipids would correlate 
with the magnitude of lipolysis and insulin resistance. 
To test our central hypothesis, multiparous Holstein 
cows were allocated into 2 groups according to their 
body condition score (BCS) at d −30 prepartum: 
lean (BCS <3.0; n = 10) or overweight (BCS >4.0; n 
= 11). Blood samples were collected at d −45, −30, 
−15, and −7, relative to expected parturition, and at 
d 4 postpartum. Plasma glucose, insulin, nonesterified 
fatty acids (NEFA), and β-hydroxybutyrate (BHBA) 
concentrations were measured, and insulin sensitivity 
was estimated. The concentrations of individual plasma 
ceramide and glycosylated ceramide were determined 
using liquid chromatography-based mass spectrometry. 
Results demonstrated that greater adiposity was as-
sociated with a greater loss in body condition during 
late pregnancy. Overweight cows had greater circulat-
ing concentrations of glucose, insulin, and NEFA, and 
lower insulin sensitivity relative to lean cows. We de-
tected 30 different sphingolipids across 6 lipid classes 
with acyl chains ranging from 16 to 26 carbons. The 
most abundant plasma sphingolipids detected were 
C24:0-ceramide, C24:0-monohexosylceramide, and 
C16:0-lactosylceramide. Plasma concentrations of total 
ceramide and monohexosylceramide increased as lacta-
tion approached, and saturated ceramide and mono-
hexosylceramide were elevated in cows with greater 
adiposity relative to those with a lean phenotype. Plas-
ma ceramides (e.g., C24:0-ceramide) were positively 
correlated with plasma NEFA and inversely correlated 
with insulin sensitivity. Our data demonstrate a remod-
eled plasma sphingolipidome in dairy cows transition-
ing from late pregnancy to lactation characterized by 
a concomitant increase in plasma ceramides with the 
development of peripartal insulin resistance.
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INTRODUCTION
Periparturient dairy cows experience an elevated de-
mand for glucose due to an increased requirement by 
the mammary gland for lactose synthesis (Bell, 1995). 
Dairy cattle transitioning from late pregnancy to early 
lactation develop insulin resistance (Bell and Bauman, 
1997) as a metabolic adaptation to energy deficit. In-
sulin resistance facilitates an increase in hepatic gluco-
neogenesis and a decrease in glucose uptake by skeletal 
muscle and adipose tissue (Bell, 1995; Spachmann et 
al., 2013). Consequently, circulating glucose is spared 
for lactose synthesis, a major osmotic regulator of milk 
secretion. To increase NEFA availability for β-oxidation 
in peripheral tissues and re-esterification in the mam-
mary gland, the periparturient dairy cow mobilizes 
triacylglycerol stores in adipose tissue (Drackley et al., 
2005; Drackley and Andersen, 2006). Because insulin is 
an antilipolytic hormone, insulin resistance can further 
increase adipose tissue lipolysis (Pires et al., 2007a,b). 
Collectively, the transition dairy cow adapts to energy 
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insufficiency by modifying peripheral insulin action to 
augment glucose economy.
An increase in prepartum adiposity can predispose 
dairy cows to a greater magnitude of insulin resis-
tance during early lactation (Holtenius et al., 2003; 
Holtenius and Holtenius, 2007). The greater extent of 
insulin resistance in overweight peripartal dairy cows 
can contribute to excessive adipose tissue lipolysis 
and thus greater metabolic disease risk (e.g., hepatic 
steatosis and ketosis). Although insulin resistance in 
dairy cattle transitioning from pregnancy to lactation 
is mediated in part by growth hormone (Bell and Bau-
man, 1997), considerable evidence supports a causative 
role of long-chain saturated fatty acids as antagonists 
of whole-body insulin sensitivity (Boden, 1997; Funaki, 
2009). The ability of surplus saturated fatty acyl-CoA 
to inhibit insulin action appears to be mediated by the 
structurally diverse sphingolipid ceramide (Chavez and 
Summers, 2012).
Although ceramides were previously believed to be 
merely structural elements of cell membranes, recent 
discoveries demonstrate that ceramides are directly 
implicated in evolutionarily conserved cellular pro-
cesses, such as cell cycle arrest, apoptosis, and stress 
responses (Hannun and Obeid, 2008). Ceramides can 
be (1) formed by de novo synthesis initiated by the 
condensation of palmitoyl-CoA via action of serine 
palmitoyltransferase, (2) formed by hydrolysis of sphin-
gomyelin by either acid or neutral sphingomyelinases, 
or (3) salvaged from complex sphingolipids that are 
broken down into sphingosine and reacylated (Figure 1; 
Hirabayashi et al., 2006). An increase in palmitoyl-CoA 
availability upregulates de novo ceramide synthesis and 
sphingomyelin hydrolysis in peripheral tissues of obese 
insulin resistant mice with hepatic steatosis, responses 
that contribute to ceramide accumulation in tissues and 
plasma (Cuschieri et al., 2007; Holland et al., 2011).
The extent of insulin resistance correlates with the 
concentrations of ceramide in plasma collected from 
obese humans with type 2 diabetes, most notably 
C24:0-ceramide, which is the most abundant ceramide 
species in human circulation (Haus et al., 2009). Plasma 
Figure 1. Metabolic pathways of ceramide synthesis. Ceramide can be generated by 3 pathways: de novo synthesis initiated by the conden-
sation of palmitoyl-CoA and serine to form 3-ketosphinganine; hydrolysis of sphingomyelin; or breakdown of complex sphingolipids via a series 
of reactions referred to as the salvage pathway. Complex sphingolipids have various acyl chain lengths varying in carbon length and degree of 
saturation. For simplicity, only C16:0-linked sphingolipids and glycosphingolipids are illustrated. Monohexosylceramides consist of a single sugar 
residue, either glucose or galactose (galactosylceramide is not shown).
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ceramide is transported as components of low-density 
lipoproteins (LDL) of hepatic origin that contribute 
to the pathophysiology of whole-body insulin resis-
tance. Although the mechanisms are not completely 
understood, an increase in the level of LDL enriched 
with C24:0-ceramide decreases whole-body and skeletal 
muscle glucose uptake in lean mice, a response ac-
companied by C24:0-ceramide accrual in the plasma 
membrane and reduced insulin-stimulated protein ki-
nase B phosphorylation (Boon et al., 2013). The effect 
of endogenous, long-chain plasma ceramide on lipolysis 
are not known; however, culturing 3T3-L1 adipocytes 
with exogenous hydrophilic C2:0-ceramide can increase 
lipolysis by suppressing insulin-stimulated activation 
of cyclic nucleotide phosphodiesterase 3B (Mei et al., 
2002). The inhibitory effect of ceramide on insulin sig-
naling is ameliorated by treatments that decrease de 
novo ceramide synthesis (e.g., reducing palmitic acid 
availability or pharmacological inhibition; Mei et al., 
2002; Holland et al., 2007; Ussher et al., 2010).
Although the link between NEFA mobilization and 
metabolic disease has been extensively studied (Drack-
ley and Andersen, 2006), the relationship between 
circulating ceramides, lipolysis, and insulin sensitiv-
ity has not been defined. Considering the recognized 
association between lipotoxicity-induced ceramide 
accumulation in plasma and the development of in-
sulin resistance in overweight monogastric animals, 
we hypothesized that plasma ceramide concentrations 
would increase concomitantly with NEFA availability 
and the decline in insulin sensitivity characteristic 
of the ruminant dairy cow transitioning from late 
pregnancy to early lactation. We further hypothesized 
that overweight peripartal cows would exhibit greater 
concentrations of ceramide in plasma and magnitude 
of insulin resistance compared with lean cows. To 
test our hypotheses, we used liquid chromatography 
coupled with mass spectrometry to perform a sphingo-
lipidomic analysis of plasma ceramides and glycosyl-
ated ceramides, an approach described by Merrill et 
al. (2009).
MATERIALS AND METHODS
Experimental Design
Experimental procedures were approved by the West 
Virginia University Institutional Animal Care and Use 
Committee (Morgantown). The experiment was com-
pleted at Dovan Farms, WVU Agricultural Research 
and Education Partner, and a 700-Holstein cow com-
mercial dairy farm (located in Berlin, PA). Nonlactat-
ing, pregnant, multiparous Holstein cows (n = 21) were 
enrolled in the study 45 d before expected parturition 
and allocated to 1 of 2 groups according to their adi-
posity at d −30 relative to calving, as either lean (BCS 
2.9 ± 0.22, n = 10) or overweight (BCS 4.1 ± 0.10, n 
= 11). Parity was not different between BCS groups 
(P > 0.9), averaging 3.5 ± 0.82 and 3.45 ± 1.08 for 
lean and overweight cows, respectively. Diets were for-
mulated to meet nutrient recommendations and cows 
were fed once and twice daily during pregnancy and 
lactation, respectively. All diets were fed for ad libitum 
intake with free access to water. Ingredient and nutri-
ent compositions of the diets fed during the experiment 
are shown in Table 1. Samples of TMR were obtained 
weekly throughout the experiment, and DM content 
was determined by drying at 60°C until a static weight 
was observed. Weekly TMR samples were submitted 
to a commercial laboratory for nutrient composition 
analysis by near-infrared spectroscopy (Cumberland 
Valley, Cumberland, MD; AOAC International, 1995; 
method 989.03).
Body weights and BCS were recorded weekly. Three 
trained investigators independently recorded BCS for 
all cows and data were averaged for each cow at d −45, 
−30, −15, −7, 4, 14, and 21 relative to expected par-
turition, postpartum using a 1.0 to 5.0 scale (Wildman 
et al., 1982). Blood samples (10 mL) were collected by 
coccygeal venipuncture at d −45, −30, −15, −7, and 
4 relative to expected parturition. Blood was kept on 
ice for 30 min until centrifugation at 3,400 × g for 10 
min. Following centrifugation, plasma was removed and 
snap-frozen in liquid nitrogen and then stored at −80°C 
until further analysis. Milk production was recorded 
from d 2 to 21 postpartum. Milk samples were collected 
at d 4 and 10 postpartum, preserved using Bronopol 
tablets (D&F Control Systems, San Ramon, CA), and 
stored at 4°C for milk component analysis.
Plasma samples were analyzed for glucose, insulin, 
NEFA, BHBA, and ceramides. Plasma concentrations 
of glucose, NEFA, and BHBA were determined by 
enzymatic methods using commercial kits (Autokit 
Glucose, HR Series NEFA-HR (2) and Autokit 3-HB, 
respectively; Wako Chemicals USA Inc., Richmond, 
VA). Plasma concentrations of insulin were determined 
by ELISA using a commercial product (Mercodia Bo-
vine Insulin ELISA; Mercodia AB, Uppsala, Sweden). 
All spectrophotometric measurements were conducted 
using a SpectraMax Plus 384 Microplate Reader (Mo-
lecular Devices, Sunnyvale, CA). Intra- and interassay 
CV were 3.8 and 3.0%, 2.6 and 7.7%, 2.3 and 9.5%, and 
3.7 and 16.6%, for glucose, NEFA, BHBA, and insulin, 
respectively. Individual milk samples were analyzed for 
fat, true protein, and lactose concentrations and SCC 
by mid-infrared spectroscopy (Dairy One, Ithaca, NY; 
AOAC, 1990; method 972.160) within 1 wk of collec-
tion.
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Ceramide Measurements
Plasma extraction was conducted using a modified 
Bligh and Dyer procedure including ceramide C12:0 
as an internal standard (Avanti Polar Lipids, Alabas-
ter, AL; Haughey et al., 2004; Bandaru et al., 2013). 
Plasma extracts were dried using a nitrogen evaporator 
and resuspended in pure methanol for analysis. Sample 
extracts were handled using an autosampler (Leap 
Technologies Inc., Carrboro, NC) that introduced ex-
tracts into an HPLC (PerkinElmer, Boston, MA) with 
a C18 reverse-phase column (Phenomenex, Torrance, 
CA). Individual species of ceramide were separated by 
gradient elution and injected into an electrospray ion 
source coupled to a triple quadrupole mass spectrom-
eter (API3000; AB Sciex Inc., Thornhill, ON, Canada; 
Bandaru et al., 2007, 2011, 2013). Ion spray voltage 
was 5,500 V at a temperature of 80◦C with a nebulizer 
gas of 8 psi, curtain gas 8 psi, and collision gas 4 psi. 
Declustering potential was 80 V, focusing potential 400 
V, entrance potential 10 V, collision energy 30 V, and 
collision cell exit potential 18 V. Individual ceramide 
species were detected by multiple reaction monitor-
ing. Six-point calibration curves (0.1 to 750 ng/mL) 
were constructed by plotting the area under the curve 
for each calibration standard, C16:0-, C18:0-, C20:0, 
C22:0-, and C24:0-ceramide, normalized to C12:0-
ceramide. Sphingolipid concentrations were determined 
by curve fitting the identified ceramide species based 
on acyl-chain length. Quantification of spectral data 
was performed using Analyst 1.4.2 and MultiQuant 
software (AB Sciex Inc.).
Table 1. Ingredients and nutrient composition (% of DM unless otherwise noted) of diets fed to lean and 
overweight cows during the transition from late pregnancy to early lactation
Item
Diet
d −60 to −21 d −21 to parturition Lactation
Ingredient
 Corn silage 32.2 30.7 42.4
 Mixed grass haylage 29.8 28.4 7.0
 Mixed grass hay 13.9 13.2 2.1
 Dry ground corn  — 14.4
 Prepartum mix1 14.7 13.9 —
 Lactation mix A2 — — 14
 Aminoplus 9.4 9.0 4.7
 Cottonseed with lint — — 4.5
 Sugar cane syrup — — 3.6
 Lactation mix B3 — — 4.5
 Close-up supplement4 — 4.8 2.7
 Rumensin5 — — 0.1
Nutrient composition    
 DM, % 49.1 49 47.4
 NDF 48 49 33.4
 Forage NDF 42.8 43.7 25.1
 Forage NDF, % of NDF 89.2 89.2 75.3
 ADF 32 32.5 21.4
 CP 12.3 12.2 16.5
 Starch 15 14.7 24.8
 Crude fat 3.1 3.4 4.4
 Ash 7.4 7.5 7.6
1Mix contained 27% commercial dry cow mix with Animate (Phibro Animal Health Corp., Teaneck, NJ), 17.3% 
ground corn, 17.3% crimped oats, 13% corn distillers, 12.9% soybean meal, 4.3% calcium carbonate, 4.3% 
calcium sulfate, 2.6% Omnigen AF (Phibro Animal Health Corp.), 1.1 Monocalcium phosphate, and < 1% of 
each of the following: Sel-plex 600 (Alltech Biotechnology, Nicholasville, KY) and vitamin E.
2Mix contained 33.6% citrus pulp, 19% soybean meal. 15.6% canola meal, 14% soybean hulls, 4.5% calcium 
carbonate, 4.5% sodium bicarbonate, 2.8% urea, 2.7% fat, 2.4% sodium chloride, and <1% from each of the 
following: Monocalcium phosphate, biotin, and Rumensin 90 (Elanco Animal Health, Greenfield, IN). 
3Mix contained 43.6% Fermenten (Church and Dwight Co., Princeton, NJ), 21.8% calcium carbonate, 10.8% 
soybean hulls, 7.8% Mintrex blend (Novus International Inc., St. Charles, MO), 5.2% blood meal, 3.5% mag-
nesium oxide, 2.6% Celmanax (Vi-COR, Mason City, IA), 2.6% Omnigen (Phibro Animal Health Corp.), and 
<1% of each of the following: vitamin E, selenium selenite, and selenium yeast 600. 
4Mix contained 74.5% ground oats, 15.3% commercial amino acid, 8% Reashure (Balchem Encapsulates, Slate 
Hill, NY), and <1% of each of the following: vitamin E and Niashure (Balchem Corporation, New Hampton, 
NY). 
5Rumensin for dairy included at 4,890 mg/kg.
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Calculations and Statistical Analysis
Plasma glucose, insulin, NEFA, and BHBA concen-
trations were measured, and insulin sensitivity was 
estimated using the revised quantitative insulin sen-
sitivity check index (RQUICKI; Holtenius and Hol-
tenius, 2007), where RQUICKI = 1/[log (glucose) + log 
(insulin) + log (NEFA)], and glucose = basal glucose 
(mg/dL), insulin = basal insulin (μU/mL), and NEFA 
= basal NEFA (mmol/L), such that lower RQUICKI 
values suggest reduced whole-body insulin sensitivity, 
and higher values are indicative of elevated whole-body 
insulin sensitivity. Changes in BCS and BW of lean 
and overweight cows were calculated as the differences 
between values at d −21 and −7, and the differences 
between d 4 and 21, relative to parturition. Somatic cell 
score was calculated from SCC for statistical analysis, 
using the following logarithmic transformation (Ali and 
Shook, 1980), where SCS = Log2 (SCC/100,000) + 3.
Changes in BCS and BW pre- and postpartum were 
analyzed using the GLM procedure of SAS (version 9.3; 
SAS Institute Inc., Cary, NC). All data for plasma and 
milk variables were analyzed as repeated measures over 
time relative to parturition under the MIXED proce-
dure of SAS (SAS Institute Inc.). The statistical model 
included the random effect of cow nested within BCS 
and the fixed effects of BCS, day relative to parturition, 
and their interaction. The most appropriate covari-
ance structure for the repeated-measures analysis was 
selected for each variable after evaluating 7 different 
covariance structures (variance components, first-order 
autoregressive, heterogeneous first-order autoregressive, 
compound symmetry, heterogeneous compound sym-
metry, first-order ante-dependence, and unstructured), 
and the structure with the smallest Akaike’s information 
criterion coefficient was selected for analysis. Modeling 
of the covariance structure allowed the identification 
of patterns that best describe relationships between 
the repeated measures in the model. The method of 
Kenward-Roger was used for calculation of denomina-
tor degrees of freedom. Preplanned contrasts were used 
to evaluate differences between lean and overweight 
cows at each time point. Relationships between select 
ceramides were evaluated by random regression, using 
the MIXED procedure of SAS (SAS Institute Inc.). 
The full model included the random effect of cow and 
the linear and quadratic effects of each predictor. Qua-
dratic effects were removed from the model based on fit 
by Akaike’s information criterion scores when P > 0.05. 
Denominator degrees of freedom were calculated by 
the Satterthwaite method. Studentized residual values 
>3.0 or < −3.0 were considered outliers and removed 
from the analysis (typically 1 per response variable). 
Nonparametric Spearman rank-order correlations were 
performed to determine associations between plasma 
sphingolipids and NEFA levels, and between sphingo-
lipids and RQUICKI values. All results are expressed 
as least squares means and their standard errors, unless 
stated otherwise. Significance was declared at P < 0.05 
and trends at P < 0.10.
Figure 2. (A) Timeline of BCS records during the transition from 
late pregnancy to early lactation; (B) changes in BCS prepartum; and 
(C) changes in BW prepartum. Changes in BCS and BW prepartum 
correspond to the difference between values recorded at d −30 and −7 
relative to parturition. Overweight dairy cows lost more prepartum 
body condition and BW, relative to lean cows. Data are represented as 
least squares means and their standard errors. *P < 0.05; †P < 0.10.
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RESULTS AND DISCUSSION
Overweight dairy cows transitioning from late preg-
nancy to early lactation will mobilize more adipose to 
meet energy demands than lean cows (Rukkwamsuk 
et al., 1999). To validate this response, BCS and BW 
were evaluated in lean and overweight transition cows 
(Figure 2). Cows that were overweight experienced ac-
celerated BCS loss (P < 0.01) and tended to lose more 
BW (P = 0.10) during late pregnancy; however, no 
differences in the rate of BCS or BW loss were detected 
during lactation (data not shown). Milk yield increased 
during early lactation but was not affected by BCS 
(29.4 ± 1.2, 37.5 ± 1.0, 39.3 ± 1.0 and 42.1 ± 1.1 kg/d, 
for 4, 10, 14 and 21 DIM, respectively; P < 0.001). Al-
though no change was observed for milk fat or lactose 
yield, a tendency for a BCS × day relative to parturi-
tion interaction was found for increased milk protein 
yield in overweight cows at 10 DIM (1.38 vs. 1.15 kg/d; 
P = 0.06). No significant response was detected for 
SCS; however, overweight cows tended to have an el-
evated SCS at 10 DIM relative to lean cows (2.27 vs. 
1.86, respectively; P = 0.10)—a potential indicator of 
compromised mammary gland immune function.
In overweight humans, elevated plasma concentra-
tions of glucose, insulin, and NEFA are markers as-
sociated with the development of insulin resistance, 
hallmark characteristics of type 2 diabetes (Reaven 
et al., 1988; Thévenod, 2008). Comparably, Holtenius 
and Holtenius (2007) demonstrated a negative linear 
relationship between adiposity and RQUICKI (i.e., 
cows with a high BCS have a low RQUICKI value), an 
observation supported by reduced glucose disappear-
ance following a glucose tolerance test in overweight 
cows (Holtenius et al., 2003; Jaakson et al., 2013). For 
validation, we measured the plasma concentrations of 
glucose, insulin, and NEFA, and calculated RQUICKI 
values for lean and overweight cows during the transi-
tion from pregnancy to lactation (Figure 3). Compared 
with lean cows, plasma glucose concentrations were 
greater in overweight animals at d −15 and −7 rela-
tive to parturition (P < 0.05). Insulin concentrations 
Figure 3. Plasma concentrations of (A) glucose, (B) insulin, and (C) NEFA, of lean and overweight dairy cattle transitioning from late preg-
nancy to early lactation; (D) estimated insulin sensitivity as measured by the revised quantitative insulin sensitivity check (RQUICKI), where 
RQUICKI was calculated as follows: 1/[log(glucose) + log(insulin) + log(NEFA)]. Lower RQUICKI values are indicative of reduced insulin 
sensitivity. Overweight dairy cows are insulin resistant before onset of lipolysis. Data are least squares means and their standard errors. *P < 
0.05; †P < 0.10.
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were higher in overweight cows at d −30 and −15 (P 
< 0.01), and tended to be greater at d 4 (P = 0.06). 
A progressive decline in plasma insulin concentrations 
was observed, being 25 and 55% lower at d −7 and 
4, respectively, relative to d −30 (P < 0.001). Plasma 
NEFA concentrations increased by 30, 149, and 321% 
on d −15, −7 and 4, respectively, relative to d −30 
(P < 0.001). As expected, overweight cows had higher 
NEFA concentrations at d −15 (P < 0.05), and tended 
to be higher at d −7 and 4 relative to parturition (P 
= 0.06). The observed increase in plasma NEFA and 
decrease in plasma insulin at the onset of lactation are 
characteristic homeorhetic adaptations to maximize 
milk synthesis, responses linked with lower voluntary 
energy intake (Drackley et al., 2005). These physi-
ological changes were associated with lower RQUICKI 
values postpartum (P < 0.001), indicative of reduced 
insulin sensitivity. Specifically, RQUICKI decreased by 
8, 15, and 14% on d −15, −7, and 4, respectively, rela-
tive to d −30 (P < 0.001). Compared with lean cows, 
insulin sensitivity was significantly lower at d −30, 
−15, −7 and 4 relative to parturition (P < 0.05). We 
also observed lower RQUICKI values in dairy cattle 
with greater adiposity as early as d −45 (P = 0.07), 
a pathological response that preceded prepartum el-
evations in plasma glucose, insulin, and NEFA. The 
observed reductions in prepartum insulin sensitivity 
may relate to antagonism of adipose tissue insulin sig-
nal transduction by saturated fatty acids in overweight 
cows (Boden, 1997), an action that could explain the 
observed acceleration in adipose tissue NEFA mobiliza-
tion. Plasma concentrations of BHBA were not affected 
by BCS; however, BHBA was 40% higher at d 4 relative 
to d −30 (465 vs. 333 μmol/L, respectively; P < 0.01).
The acyl chain specificity of 6 dihydroceramide syn-
thases produces structurally diverse sphingolipids (Park 
and Pewzner-Jung., 2013). To elucidate the structural 
diversity of ceramide and glycosylated ceramide in 
dairy cows, we used liquid chromatography coupled 
with mass spectrometry to separate 30 plasma species 
by acyl chain length including long-chain ceramides, 
monohexosylceramides, and lactosylceramides, as well 
as a limited number of dihydro species (Figure 4). Simi-
lar to humans and rodents (Ichi et al., 2006; Haus et 
al., 2009), C16:0- and C24:0-ceramide were the most 
abundant plasma ceramides, representing 30 and 58% 
of total ceramide, respectively, across lean and over-
weight cows. Similarly, C24:0-monohexosylceramide 
and C16:0-lactosylceramide represented the major 
plasma monohexosylceramide and lactosylceramide 
species, respectively. In humans, approximately 98% 
of plasma ceramides are found within liver-derived 
lipoprotein subfractions (i.e., high, low, and very low 
density lipoproteins; Lightle et al., 2003; Boon et al., 
Figure 4. Plasma composition of (A) ceramides, (B) monohexo-
sylceramides, and (C) lactosylceramides in lean and overweight dairy 
cows transitioning from late pregnancy to early lactation (d −30 to 
4 relative to parturition). C16:0-dihydroceramide, C16:0-dihydro-
monohexosylceramide, and C16:0-dihydro-lactosylceramide are not 
included; C16:0- and C24:0-ceramide are the high-abundant ceramides 
in bovine plasma. Data presented as mean abundance ± SD.
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2013); however, the origin of ceramides over time and 
between BCS groups in this study is unknown and will 
require further definition.
Measurement of plasma ceramides can be a means 
to diagnose the severity of insulin resistance in humans 
experiencing hyperlipidemia and nonalcoholic fatty 
liver disease (Haus et al., 2009). Therefore, we com-
pared the plasma ceramide and glycosylated ceramide 
profiles with the development of insulin resistance in 
lean and overweight dairy cows (Figure 5). Plasma con-
centrations of total ceramide increased as parturition 
approached (Figure 6); however, these responses were 
accelerated in dairy cows exhibiting greater adiposity, 
NEFA mobilization, and magnitude of insulin resistance. 
Of interest, plasma C24:0-ceramide, the most abundant 
ceramide in bovine plasma, increased by 92% on d 4 
Figure 5. For visualization purposes, the heat map represents the magnitude of mean-centered, fold change increases (red) or decreases (blue) 
for each sphingolipid or glycosphingolipid, relative to lean cows sampled at d −30 prepartum. Comparisons should be made within metabolite. 
Plasma ceramides, monohexosylceramides, and lactosylceramides are elevated in overweight dairy cows transitioning from gestation to lactation. 
The heat map was generated using MetaboAnalyst 2.0 (Xia et al., 2012).
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relative to d −30 (P < 0.001; Figure 7), and tended 
to be greater in overweight cows at d −7 (P = 0.09). 
Concentrations of C18:0-, C18:1-, C20:0-, C22:0, C22:1, 
and C24:1-ceramide were also significantly greater in 
overweight cows during the peripartal period (P < 0.05; 
Supplemental Figure S1; http://dx.doi.org/10.3168/
jds.2015-9519), relative to lean cows, and C26:0- and 
C26:1-ceramide concentrations tended to be increased 
in overweight dairy cows on d 4 and d −15, respec-
tively, relative to d −30 (P = 0.06). In contrast, plasma 
C16:0-ceramide concentrations did not change with 
time or score of adiposity (Figure 7). Because palmitic 
acid is a required substrate for de novo synthesis of 
all sphingolipids including ceramides, glycosylated ce-
ramides, and sphingomyelins (i.e., palmitic acid is part 
of the sphingoid backbone), palmitic acid availability 
may have been limited for C16:0-ceramide synthesis in 
overweight cows.
De novo synthesis of ceramide is contingent on the 
fatty acyl-CoA-dependent acylation of sphinganine to 
form dihydroceramide, a reaction mediated by dihydro-
ceramide synthase. We measured one dihydroceramide 
in bovine plasma, C16:0-dihydroceramide (Supple-
mental Figure S2; http://dx.doi.org/10.3168/jds.2015-
9519). Plasma C16:0-dihydroceramide tended to be 
greater in overweight cows at d −15 (+47%; P = 0.07). 
The elevated concentration of plasma C16:0-dihydroc-
eramide is indicative of increased ceramide anabolism 
in tissues of dairy cows transitioning from pregnancy 
to lactation. We also detected a significant positive as-
sociation between plasma C16:0-dihydroceramide and 
C16:0-ceramide across all sampled cows (P < 0.001; 
Supplemental Figure S3; http://dx.doi.org/10.3168/
jds.2015-9519). The strong relationship between these 
sphingolipids may be explained by enhanced activity of 
hepatic dihydroceramide desaturase in transition dairy 
cows; however, additional research is needed to confirm 
this hypothesis.
Glycosylated ceramides include monohexosylcerami-
des (e.g., glucosylceramide and galactosylceramide) 
and lactosylceramides, glycosphingolipids synthesized 
from ceramide and precursors for monosialodihexosyl-
ganglioside synthesis (GM3, a ganglioside; Figure 1). 
Similar to ceramide, monohexosylceramide levels are 
elevated in plasma from obese, insulin-resistant ro-
dents (Chavez et al., 2014). To determine whether a 
similar relationship exists in overweight dairy cows, we 
profiled these plasma glycosphingolipids (Figures 5, 6, 
and 7 and Supplemental Figures S4 and S5; http://
dx.doi.org/10.3168/jds.2015-9519). Subsequent to the 
prepartum increases in plasma ceramides, we detected 
an increase in the concentrations of most plasma 
monohexosylceramides in overweight cows postpartum 
(Figure 5). These results were expected because mono-
hexosylceramide synthesis is contingent on ceramide 
availability (Figure 1). For example, as plasma NEFA 
and ceramide levels increased with time, the concen-
tration of C24:0-monohexosylceramide (the most 
Figure 6. Plasma concentrations (ng/mL) of total (A) ceramide, 
(B) monohexosylceramide, and (C) lactosylceramide in lean and over-
weight peripartal dairy cows. Data are represented as least squares 
means and their standard errors. *P < 0.05.
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abundant plasma monohexosylceramide) increased (P 
< 0.001; Figure 7). Relative to adiposity, plasma C24:0-
monohexosylceramide was elevated in overweight cows 
at d 4 postpartum (BCS × day relative to parturi-
tion, P < 0.01). Similar observations were observed 
for C24:0-lactosylceramide. Furthermore, we observed 
a strong positive association between C24:0-ceramide 
and C24:0-monohexosylceramide, and between C24:0-
monohexosylceramide and C24:0-lactosylceramide 
across all sampled cows (Figure 8). These results may 
indicate a coordinated regulation of synthesis for these 
sphingolipids containing the C24:0 acyl moiety in tran-
Figure 7. Plasma concentrations (ng/mL) of (A) C16:0-ceramide, (B) C24:0-ceramide, (C) C16:0-monohexosylceramides, (D) C24:0-
monohexosylceramide, (E) C16:0-lactosylceramide, and (F) C24:0-lactosylceramide in lean and overweight transition dairy cows. Plasma con-
centrations of C24:0-linked ceramide, monohexosylceramide, and lactosylceramide were elevated in overweight cows transitioning from late 
pregnancy to early lactation, relative to lean cows. Data are represented as least squares means and their standard errors. *P < 0.05; †P < 0.10.
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sition dairy cow tissues. In contrast to total ceramide 
and monohexosylceramide, total lactosylceramide con-
centrations were not modified with enhanced adiposity 
(Figure 6); however, C16:0-lactosylceramide (the most 
abundant plasma lactosylceramide) concentrations 
were lower in overweight cows compared with lean cows 
(P < 0.01).
Increased circulating NEFA can promote insulin re-
sistance by promoting ceramide accumulation in plasma 
and peripheral tissues of humans and rodents (Watt et 
al., 2012). Considering that NEFA can induce insulin 
resistance in dairy cows (Pires et al., 2007a), we hy-
pothesized that plasma ceramide concentrations would 
increase concomitantly with NEFA availability and the 
development of insulin resistance. To test this hypoth-
esis, we performed a Spearman correlation analysis 
to identify significant correlations between individual 
sphingolipid species, and NEFA levels or RQUICKI 
values (Figure 9). As expected, NEFA correlated nega-
tively with insulin sensitivity (r = −0.62, P < 0.05). 
The majority of ceramides and monohexosylceramides 
were positively correlated with NEFA concentrations 
and negatively correlated with insulin sensitivity. Sig-
nificant positive correlation coefficients between NEFA 
levels and multiple ceramide species were detected, 
ranging from 0.23 to 0.60 (P < 0.05), with the strongest 
correlations observed for C24:0-ceramide, total mono-
hexosylceramide, and C22:0-monohexosylceramide (P 
< 0.001). Significant negative correlation coefficients 
between ceramides and RQUICKI values ranged from 
−0.33 to −0.22 (P < 0.05), and included total ceramide 
as well as individual ceramide subspecies (i.e., 20:0, 
C22:0, C24:0, C24:1, and C26:0). A remarkably similar 
relationship has been observed in obese type 2 diabetic 
patients and lean healthy control subjects (Haus et 
al., 2009). In further support, baseline measurements 
of C20:0-, C24:0-, and C24:1-ceramide were inversely 
related to insulin sensitivity in overweight adults (Dubé 
et al., 2011). In contrast, we did not detect significant 
correlations between plasma glycosylated ceramides 
(i.e., monohexosylceramides or lactosylceramides) and 
estimated whole-body insulin sensitivity. Comparably, 
dihydroceramide and ceramide classes correlate with 
type 2 diabetes and prediabetes in humans, correlations 
not observed for monohexosylceramide or lactosylce-
ramide (Meikle et al., 2013).
The development of insulin resistance and lipolysis 
represent coordinated shifts in metabolism to support 
lactation. Reduced insulin stimulation during the tran-
sition from gestation to lactation allows adipose tissue 
metabolism to change from lipogenic to lipolytic (Mc-
Namara, 1991), a shift that facilitates hepatic NEFA 
processing (Drackley et al., 2005). Although ceramides 
can be synthesized from NEFA and are known ef-
fectors of insulin resistance in monogastrics, little is 
known of their involvement in the homeorhetic process 
that modifies nutrient partitioning in cows transition-
ing from gestation to lactation. Because our observed 
increases in plasma ceramide concentrations occurred 
concomitantly with changes in NEFA, insulin, and in-
sulin sensitivity in both lean and overweight cows dur-
ing the transition from gestation to lactation (Figure 3, 
Figure 6, and Figure 9), the accumulation of ceramide 
may represent a homeorhetic adaptation that allows 
periparturient cows to undergo these characteristic 
shifts in metabolism.
Given that the mammalian sphingolipidome com-
prises a vast array of complex lipids, a major challenge 
Figure 8. Random regression analysis between plasma concentra-
tions of (A) C24:0-ceramide and C24:0-monohexosylceramide, and (B) 
C24:0-monohexosylceramide and C24:0-lactosylceramide in lean and 
overweight dairy cows during the transition from late pregnancy to early 
lactation. Coefficients of determination (R2) represent the association 
between observed and model predicted values when accounting for the 
random effect of cow. Plasma C24:0-ceramide was positively associated 
with C24:0-monohexosylceramide, and C24:0-monohexosylceramide 
was positively associated with C24:0-lactosylceramide. Data represent 
measurements for d −30, −15, −7, and 4 relative to parturition.
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Figure 9. Nonparametric Spearman rank-order correlations of circulating ceramides to (A) plasma NEFA, and (B) revised quantitative 
insulin sensitivity check (RQUICKI), where RQUICKI was calculated as follows: 1/[log(glucose) + log(insulin) + log(NEFA)]. Lower RQUICKI 
values are indicative of reduced insulin sensitivity. Plasma ceramides were positively correlated with circulating NEFA, and negatively correlated 
with insulin sensitivity in dairy cows transitioning from late pregnancy to lactation. ***P < 0.001; **P < 0.01; *P < 0.05; †P < 0.10.
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in the field of sphingolipid biology is to identify which 
species are the primary effectors of insulin resistance 
in different tissues. A limitation of the current study 
is that we did not evaluate ceramide metabolism or 
insulin signaling in liver, skeletal muscle, or adipose 
tissue. Future studies will need to use rapidly advanc-
ing sphingolipidomics-based methodologies to address 
whether plasma or tissue ceramide can mediate the de-
velopment of insulin resistance in periparturient dairy 
cows.
CONCLUSIONS
Insulin resistance accelerates lipolysis and increases 
metabolic disease risk in periparturient dairy cattle, 
and ceramide is an inhibitor of insulin action in mono-
gastrics; however, the relationship between plasma 
ceramide and insulin resistance has not been character-
ized in peripartal cows. We conclude that ceramides 
accumulate in plasma during the progression of insulin 
resistance in overweight cows transitioning from late 
pregnancy to early lactation. These data support the 
potential involvement of ceramide in the pathological 
development of insulin resistance in dairy cattle. We 
also conclude that changes in plasma ceramide abun-
dance occur concomitantly with changes in plasma 
NEFA, insulin, and insulin sensitivity, suggesting that 
circulating ceramides may be fundamentally involved 
in the homeorhetic adaptation to early lactation. To 
evaluate these possibilities, future work should focus 
on determining whether augmented insulin resistance 
in overweight cows is caused by maladaptive changes 
in fatty acid processing that promote the synthesis and 
accumulation of ceramide, and whether antagonism 
of insulin signaling is ceramide dependent. Identifying 
the mechanisms of insulin resistance may reveal meta-
bolic pathways that can be manipulated to improve 
insulin sensitivity, reduce lipolysis, and improve cow 
health. Researchers should also evaluate the efficacy of 
plasma ceramide subspecies as diagnostic predictors for 
metabolic disease risk relative to the commonly utilized 
biomarkers NEFA and BHBA.
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